clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with clarithromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Shinozaki S et al. | Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen. | 2018 | Kaohsiung J. Med. Sci. | pmid:30041763 |
Iannone A et al. | New fecal test for non-invasive detection: A diagnostic accuracy study. | 2018 | World J. Gastroenterol. | pmid:30038469 |
Heffernan CB et al. | Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. | 2018 | Ann. Otol. Rhinol. Laryngol. | pmid:30032669 |
Hamza D et al. | Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance. | 2018 | Microb. Pathog. | pmid:30031039 |
Vianna JS et al. | The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. | 2018 | Rev. Inst. Med. Trop. Sao Paulo | pmid:29972462 |
Myojin S et al. | Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. | 2018 | Int. J. Infect. Dis. | pmid:29966711 |
Liou JM et al. | Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. | 2018 | Gastroenterology | pmid:29964036 |
Kwofie SK et al. | Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa. | 2018 | Molecules | pmid:29954088 |
Tanabe H et al. | Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. | 2018 | Ann. Clin. Microbiol. Antimicrob. | pmid:29950163 |
Sandri A et al. | Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice. | 2018 | Virulence | pmid:29938577 |
Gonzalez-Hormazabal P et al. | Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa. | 2018 | BMC Gastroenterol | pmid:29925321 |
Clarithromycin in patients with coronary artery disease. | 2018 | Med Lett Drugs Ther | pmid:29913468 | |
Li M et al. | Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori. | 2018 | Helicobacter | pmid:29873436 |
Blümel B et al. | Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing. | 2018 | Helicobacter | pmid:29873430 |
Chen J et al. | Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene. | 2018 | Ann. Clin. Microbiol. Antimicrob. | pmid:29562911 |
RodrÃguez-Sevilla G et al. | Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. | 2018 | Int. J. Med. Microbiol. | pmid:29555180 |
Leung WK et al. | Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals. | 2018 | Gastroenterology | pmid:29550592 |
Kusuki M et al. | Determination of the antimicrobial susceptibility and molecular profile of clarithromycin resistance in the Mycobacterium abscessus complex in Japan by variable number tandem repeat analysis. | 2018 | Diagn. Microbiol. Infect. Dis. | pmid:29550059 |
Brennan DE et al. | Can bacterial virulence factors predict antibiotic resistant infection? | 2018 | World J. Gastroenterol. | pmid:29531461 |
Reisfeld L et al. | Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis. | 2018 | Dis. Aquat. Org. | pmid:29516862 |
Fiorini G et al. | Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice. | 2018 | Eur J Gastroenterol Hepatol | pmid:29481383 |
Talarico S et al. | High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. | 2018 | Helicobacter | pmid:29480566 |
Takemori N et al. | A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report. | 2018 | J Med Case Rep | pmid:29454372 |
Xu R et al. | Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban. | 2018 | Eur. J. Clin. Pharmacol. | pmid:29453492 |
Tsutsui A et al. | Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. | 2018 | J. Infect. Chemother. | pmid:29428566 |
Tarhini M et al. | First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy. | 2018 | Microb. Pathog. | pmid:29428426 |
Kobayashi T et al. | The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma. | 2018 | Ann. Hematol. | pmid:29427183 |
Wang S et al. | Enhanced adsorption of ionizable antibiotics on activated carbon fiber under electrochemical assistance in continuous-flow modes. | 2018 | Water Res. | pmid:29426033 |
Jung JH et al. | Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Infection. | 2018 | Gut Liver | pmid:29212313 |
Deng J et al. | Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial. | 2018 | Int Forum Allergy Rhinol | pmid:29195025 |
Beer-Davidson G et al. | Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction. | 2018 | Helicobacter | pmid:29181860 |
Muñoz-Gómez P et al. | Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens. | 2018 | Helicobacter | pmid:29178562 |
Zagari RM et al. | Treatment of Helicobacter pylori infection: A clinical practice update. | 2018 | Eur. J. Clin. Invest. | pmid:29144559 |
Liu DS et al. | Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. | 2018 | Clin. Microbiol. Infect. | pmid:29138101 |
Redondo JJ et al. | A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene. | 2018 | Diagn. Microbiol. Infect. Dis. | pmid:29111147 |
Iwamoto J et al. | Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. | 2018 | Intern. Med. | pmid:29093413 |
Ersoy B et al. | The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs. | 2018 | J Laryngol Otol | pmid:29888693 |
Inagaki Y et al. | Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome. | 2018 | Intern. Med. | pmid:29093379 |
De Francesco V et al. | Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study. | 2018 | Dig Liver Dis | pmid:29089267 |
Cerqueira RM et al. | Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery. | 2018 | Obes Surg | pmid:29076008 |
De Lorenzi G et al. | Mycobacterium genavense Infection in a Domestic Ferret (Mustela putorius furo). | 2018 | Top Companion Anim Med | pmid:30502861 |
McNicholl AG et al. | Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial. | 2018 | Helicobacter | pmid:30141228 |
Silva GM et al. | Helicobacter pylori antimicrobial resistance in a pediatric population. | 2018 | Helicobacter | pmid:30091503 |
Bilgilier C et al. | Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori. | 2018 | Clin. Microbiol. Infect. | pmid:28669844 |
Barros S et al. | Cat Scratch Disease: Not a Benign Condition. | 2018 | Ocul. Immunol. Inflamm. | pmid:28665750 |
Ullah S et al. | Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability. | 2018 | Artif Cells Nanomed Biotechnol | pmid:28541761 |
Yoshida S et al. | Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan. | 2018 | J. Med. Microbiol. | pmid:29227218 |
Cheung KS et al. | Long-term proton pump inhibitors and risk of gastric cancer development after treatment for : a population-based study. | 2018 | Gut | pmid:29089382 |
Ribaldone DG et al. | Helicobacter pylori eradication: poor medical compliance from East to West of the world. | 2018 | Scand. J. Gastroenterol. | pmid:29383955 |
Suzuki K et al. | Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. | 2018 | Respir Investig | pmid:29325687 |